2Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3,8) breakpoint, is abnormal in digestive tract cancers[J].Cell 1996,84(4) :587-597
3Barnes LD,Garrison PN,Siprashrili Z, et al. Fhit a putative tumor suppressor in humans, is a dinucleoside 5', 5"-pl, p3-triphosphate hydrolase[ J ]. Biochemistry, 1996,35(36) : 11529-11535.
4Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity [ J ]. Proc Natl Acad Sci USA, 1997,94 (25) : 13771-13776.
5Michael D, Beer DG, Wilke CW, et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas[ J ]. Oncogene, 1997,15 (14) : 1653-1659.
6Moil M,Mimori K,Shiraishi T, et al. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus[J].Cancer Res,2000,60(5) :1177-1182.
7Kitamura A,Yashima K,Okamoto E, et al. Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis:no correlation with p53 expression and apoptosis[J]. Oncology,2001,61(3) :205-211.
8Morita M,Saeki H, Mori M,et al. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract[J]. Surgery,2002,131(1 Suppl) : S1-6.
9Shirnada Y, Sato F, Watanabe G, et al. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history[ J ]. Cancer, 2000,89 ( 1 ) : 5-11.
10Caselli M,Marchisio M,Gaudio M, et al. Fhit protein expression in human gastric cancer and related precancerous leaiona[J]. Oncology Rep,2001,8(6) : 1233-1237.
